Navigation Links
Renowned Radiologist Peter J. Julien, MD Named Radlink Chief Medical Officer
Date:2/26/2008

2005 Cedar Sinai 'Physician of the Year' and Current Radlink Board Member

Joins Team

REDONDO BEACH, Calif., Feb. 26 /PRNewswire/ -- Radlink, Inc., a fast-growing software and hardware company that has emerged as an innovative provider of medical imaging systems to healthcare providers, today named Peter J. Julien, MD, as chief medical officer.

With nearly 30 years of experience, Dr. Julien is currently director of Thoracic Imaging at Cedar-Sinai Medical Center in Los Angeles. He also has served as associate director of Radiology and director of Mammography. In 2005, Dr. Julien was named the Cedar-Sinai Physician of the Year. Dr. Julien, who is a Radlink board member, will continue his duties at Cedar-Sinai.

"Peter is an investor and board member of Radlink," said Tom Hacking, chairman and CEO. "Over the last two years he has spent countless hours working with our team to design and test software products that our niche market -- private practice physicians -- have told us they need to make a smooth transition to digital imaging. This appointment simply acknowledges publicly the important role Peter has played in the development of Radlink's imaging products."

As chief medical officer, Dr. Julien will guide Radlink's imaging strategy including new product ideas and determining how the company can best economically and technologically serve private practice physicians as their offices become digital.

"Working with Radlink over the last two years gives me a unique perspective into the company, its products and its goals," said Dr. Julien. "They are truly offering top quality and affordable products that can help change the economical landscape of medicine. My background will play an integral role in helping to accomplish these objectives and I'm honored to be on the team."

In addition to a long career at Cedar-Sinai for more than 25 years, Dr. Julien was an assistant clinical professor of
'/>"/>

SOURCE Radlink, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD
4. Peter Cummings to receive the 2007 AIChE Nanoscale Science and Engineering Forum Award
5. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
6. CareEvolution and SCHIEx Named Interoperability Finalists for 2008 Microsoft Healthcare Users Group (MS-HUG) Healthcare Innovation Awards
7. Meredith Martin Addy Named One of Top 10 Illinois Super Lawyers for 2008
8. Carl Hull Named President and Chief Operating Officer of Gen-Probe
9. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
10. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
11. Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 Illinois Super Lawyers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
(Date:1/15/2014)... A study has been launched to test whether ... could help to tackle the problem of obesity.  This unique ... surgery based in Stowmarket) and academics at University Campus Suffolk ... technology, which is inspired by equipment used to collect data ...
(Date:1/15/2014)... 15, 2014 The Microcompetition with Foreign DNA ... One of these latent viruses is the Epstein Barr Virus ... Rheumatoid arthritis (RA) is a chronic inflammatory disease that destroys ... found that RA patients have high concentrations of EBV DNA ...
(Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3
... at the 2008 Genitourinary Cancers Symposium, ... Inc. announced,today that the Company,s lead cancer ... was well-tolerated in combination with either docetaxel ... with,hormone refractory prostate cancer. Additionally, patients treated ...
... to household cleaners will benefit from new technologies and ... the National Institutes of Health (NIH) and the U.S. ... toxicity testing agreement. The concept behind this agreement is ... journal Science. , Two NIH institutes have formed ...
... 10 a.m.A summary of the National Nanotechnology Initiative (NNI) ... Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the ... report is a supplement to the Presidents Budget for ... budget request, as well as highlights of planned activities ...
Cached Biology Technology:OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 2OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 3OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 4NIH collaborates with EPA to improve the safety testing of chemicals 2NIH collaborates with EPA to improve the safety testing of chemicals 3National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights 2
(Date:4/17/2014)... Razzari of the nergie Matriaux Tlcommunications Research Centre ... John R. Evans Leaders Fund of the Canada ... state-of-the-art biotech and nanophotonics equipment. To this funding ... de l,Enseignement suprieur, de la Recherche, de la ... laboratories will help us develop new approaches for ...
(Date:4/17/2014)... Our eyes not ... with a continuous stream of information about our own movements. ... a car the world glides by us and leaves ... our brain calculates self-motion from this "optic flow". This way, ... during our own movements. Together with biologists from the University ...
(Date:4/17/2014)... eight years ago, Katia Silvera , a postdoctoral scholar ... on a field trip in a mountainous area in central ... seen before. , Unable to identify it, they contacted German ... out to be an unnamed species. So Carnevali recently named ... is the genus name, comprising about 40 species in the ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3
... this week in The Lancet Infectious Diseases ... bacterial infection that causes pneumonia, meningitis and sepsis ... a blood disorder prevalent in African children that increases ... study underscores the critical need for use of pneumococcal ...
... Could one of South America,s greatest military figures ... tuberculosis assumed at the time of his death in ... known as "El Libertador" or "The Liberator" ... Historical Clinicopathological Conference (CPC), sponsored by the University of ...
... 2010) Eighty percent of health problems and five million ... water and sanitation according to the World Water Development Report ... for rural villagers, highlights a dire need for reliable access ... aims to solve. The Lemelson-MIT Program today announced ...
Cached Biology News:Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 2Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 3Historic medical conference finds Bolivar may have been poisoned 2Historic medical conference finds Bolivar may have been poisoned 3Historic medical conference finds Bolivar may have been poisoned 4Inventor honored for tech improving access to clean water, healthcare, and business development in India 2Inventor honored for tech improving access to clean water, healthcare, and business development in India 3Inventor honored for tech improving access to clean water, healthcare, and business development in India 4
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
... (MUC3) is a glycoprotein. distributed in ... extent in breast, lung and salivary gland ... cross-reaction with MUC1 and MUC2. ... Immunogen: MUC3 tandem repeat peptide ...
... caudal-related homeobox family, is an intestine-specific transcription ... in intestinal epithelial cells. It plays an ... phenotype of differentiated villus enterocytes as well ... Clone CDX2-88 reacts with a conserved epitope ...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Biology Products: